{"altmetric_id":2638463,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["hypoxiapapers"],"posts_count":1}},"citation":{"abstract":"Anti-angiogenic therapies like bevacizumab are promising for cancer, but acquired resistance, which often includes increased invasiveness, can limit their utility. We investigated mediators of this invasive resistance using a large archive of bevacizumab-resistant glioblastoma (BRG) tissue and by developing novel xenograft models of anti-angiogenic therapy resistance.","abstract_source":"pubmed","altmetric_jid":"4f6fa62f3cf058f61000828a","authors":["Manish K Aghi","Arman Jahangiri","Smita Mascharak","Michael De Lay"],"doi":"10.1093\/neuonc\/nou208.34","first_seen_on":"2014-08-29T16:59:12+00:00","issns":["1523-5866"],"journal":"Neuro-Oncology","last_mentioned_on":1409331536,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25165287?dopt=Abstract"],"pmid":"25165287","pubdate":"2014-07-01T00:00:00+00:00","publisher_subjects":[{"name":"Neurosciences","scheme":"era"},{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms","neurology"],"title":"A C-met-\u00df1 integrin complex drives invasive resistance to anti-angiogenic therapy.","type":"article","volume":"16 Suppl 3"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":4193102,"mean":5.1241378067285,"rank":3347560,"this_scored_higher_than_pct":2,"this_scored_higher_than":115192,"rank_type":"exact","sample_size":4193102,"percentile":2},"similar_age_3m":{"total_number_of_other_articles":108326,"mean":8.1787649203785,"rank":86420,"this_scored_higher_than_pct":1,"this_scored_higher_than":518,"rank_type":"exact","sample_size":108326,"percentile":1},"this_journal":{"total_number_of_other_articles":923,"mean":2.7331952277657,"rank":849,"this_scored_higher_than_pct":1,"this_scored_higher_than":5,"rank_type":"exact","sample_size":923,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":18,"mean":6.7850588235294,"rank":18,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":18,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/hypoxiapapers\/status\/505399213044142080","license":"datasift","citation_ids":[2638463],"posted_on":"2014-08-29T16:58:56+00:00","author":{"name":"Hypoxia Adaptation","image":"https:\/\/pbs.twimg.com\/profile_images\/491585034201989120\/716F2y0d_normal.png","description":"A feed for hypoxia related papers published in NCBI, ArXiv, bioArxiv, and PeerJ","id_on_source":"hypoxiapapers","tweeter_id":"2669362848","geo":{"lt":null,"ln":null},"followers":408},"tweet_id":"505399213044142080"}]}}